Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2018 1
2019 2
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ; PROUD-PV Study Group. Gisslinger H, et al. Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31. Lancet Haematol. 2020. PMID: 32014125 Clinical Trial.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study.
Mohty M, Terpos E, Mateos MV, Cavo M, Lejniece S, Beksac M, Bekadja MA, Legiec W, Dimopoulos M, Stankovic S, Durán MS, De Stefano V, Corso A, Kochkareva Y, Laane E, Berthou C, Salwender H, Masliak Z, Pečeliūnas V, Willenbacher W, Silva J, Louw V, Nemet D, Borbényi Z, Abadi U, Pedersen RS, Černelč P, Potamianou A, Couturier C, Feys C, Thoret-Bauchet F, Boccadoro M; EMMOS Investigators. Mohty M, et al. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e401-e419. doi: 10.1016/j.clml.2018.06.018. Epub 2018 Jun 25. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30030033 Free article.
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study.
Candelaria M, González DE, Delamain MT, Bär DO, Beniwal SK, Dasappa L, Flores DH, Querol J, Guan TS, Lipatov ON, Volodicheva EM, Patel M, Safaee Nodehi SR, Fogliatto L, Paravisini A, Perez Diaz L; RTXM83 study. Candelaria M, et al. Among authors: volodicheva em. Leuk Lymphoma. 2019 Dec;60(14):3375-3385. doi: 10.1080/10428194.2019.1633632. Epub 2019 Jul 4. Leuk Lymphoma. 2019. PMID: 31272251 Clinical Trial.
[Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma].
Vorobyev VI, Gemdzhian EG, Dubrovin EI, Nesterova ES, Kaplanov KD, Volodicheva EM, Zherebtsova VA, Kravchenko SK. Vorobyev VI, et al. Among authors: volodicheva em. Ter Arkh. 2019 Jul 15;91(7):41-51. doi: 10.26442/00403660.2019.07.000322. Ter Arkh. 2019. PMID: 32598735 Russian.
[The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia].
Parovichnikova EN, Kliasova GA, Sokolov AN, Troitskaia VV, Kokhno AV, Kuz'mina LA, Shaforostova II, Ryzhko VV, Kravchenko SK, Bondarenko SN, Lapin VA, Pristupa AS, Konstantinova TS, Zagoskina TP, Ialykomov IV, Moskov VI, Anchukova LV, Kaporskaia TS, Volodicheva EM, Kaplanov KD, Kondakova EV, Samoĭlova OS, Gavrilova LV, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: volodicheva em. Ter Arkh. 2012;84(7):10-5. Ter Arkh. 2012. PMID: 23038965 Clinical Trial. Russian.